Oracle (ORCL.N) up 2.2% at $149.3 premarket after Oppenheimer upgrades stock to “outperform” from “perform”
Brokerage sets PT of $185, which implies a 26.5% upside from stock’s last close
Says selloff has cut valuation multiples by more than half since September
Calls Oracle a “strong EPS compounder”; sees EPS doubling by FY30 even after haircut to guidance
Adds that risks around OpenAI counterparty exposure, financing needs “starting to mitigate,” supported by capital-raise plans and mega-customer momentum
Also says Oracle “relatively immune” to AI disruption due to strength in ERP/financials apps; notes “underownership” among institutions
Average rating of 44 analysts covering the stock is “buy” and the median price target is $275, implying an ~88% upside from its last close - LSEG-compiled data
Oracle shares have plunged ~25% YTD, underperforming a 0.7% rise in the S&amp;P 500 (.SPX)

ORCX

ORCL

CLOU

BUZZ-Oracle rises after Oppenheimer upgrades to 'outperform'